Cough in children: features of diagnosis and choice of therapy

Author:

Malanicheva T. G.1ORCID,Ziatdinova N. V.1ORCID,Kuznetsova O. Yu.2ORCID,Ismagilova D. R.3

Affiliation:

1. Kazan State Medical University

2. Kazan Federal University

3. Republican Clinical Hospital

Abstract

Introduction. Cough is the most common symptom of acute respiratory infections, which results from inflammation of the upper and lower respiratory tract. Herbal medicines that include an ivy leaf extract preparation are widely used for the treatment of cough.Aim. To evaluate the effectiveness and safety of the ivy leaf extract preparation as a syrup in young children with acute bronchitis. Materials and methods. We observed 44 children with acute bronchitis aged 4 months up to 3 years. The main group included 24 children receiving the ivy leaf extract preparation as part of complex therapy: 2.5 ml once a day for under 1-year children, and 2.5 ml 3 times a day for children aged 1–3 years for 7–10 days. The comparison group included 20 children receiving ambroxol at an age-appropriate dose as part of complex therapy. The complex therapy for bronchitis did not differ in the groups to be compared. Clinical effectiveness was assessed by analysis of the changes in the main symptoms of the disease.Results and discussion. It was found that the intake of the ivy leaf extract preparation showed high clinical effectiveness in 91.6% of cases, which included rapid relief of the main symptoms of the disease (cough, wheezing in the lungs), a 1.7-fold reduction of the exacerbation period, a 1.8-fold decrease of the cough period. Prescription of systemic antibiotics for children with acute bronchitis was required in 12.5% patients of the treatment group, and in 25% patients of the comparison group. The overall assessment of tolerability of the ivy leaf extract preparation was rated as excellent and good in 95.8% of cases.Conclusion. Due to high clinical effectiveness and safety of the ivy leaf extract preparation, it can be recommended for common practical use in acute bronchitis children from the first days of life.

Publisher

Remedium, Ltd.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3